12th Sep 2007 13:28
Alliance Pharma PLC12 September 2007 For Immediate Release 12 September 2007 ALLIANCE PHARMA PLC ("Alliance" or "the Company") Director Share Purchase Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announcesthat Richard Wright, the Company's Finance Director who joined the Company inJune this year, has today purchased 90,768 ordinary shares of 1p each in theCompany at a price of 7.77p per share. Mr Wright's resultant shareholding is 90,768 ordinary shares, equivalent to 0.06per cent of the Company's issued share capital. For further information: Alliance Pharma plc + 44 (0) 1249 466966John Dawson, Chief Executive Richard Wright, Finance Directorwww.alliancepharma.co.uk Numis Securities + 44 (0) 20 7260 1000David PoutneyMichael Meade Buchanan Communications + 44 (0) 20 7466 5000Mark Court/Rebecca Skye Dietrich Notes to editors About Alliance Pharma Alliance Pharma, founded in 1996, is an AIM listed speciality pharmaceuticalcompany based in Chippenham, Wiltshire, UK. The company has a strong trackrecord of acquiring the rights to established niche brands and owns, or shares,the rights to 34 branded pharmaceutical products. Alliance Pharma's products are prescribed in the treatment of a wide range ofconditions and include brands used in periodontitis (a serious gum disease), theprevention of heart disease, in Parkinson's disease, in nutrition, in nasalinfections, in the treatment of dermatological conditions and in childbirth.Alliance Pharma's sales are mainly prescription driven. Its products aredistributed to hospitals directly and to pharmaceutical wholesalers whichservice both hospital and retail pharmacies with their prescriptionrequirements. Alliance Pharma joined the AIM market of the London Stock Exchange in December2003 and trades under the symbol APH. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Alliance Pharma